文献速递鼻科

慢性鼻炎治疗后鼻腔微生物群落的变化:一项观察性研究

Nasal Microbial Community Shifts Following Treatment in Chronic Rhinitis: An Observational Study.
PubMed 文献 · Laryngoscope · 2025-06-20

这项观察性研究纳入22例慢性鼻炎患者,在治疗前后采集鼻腔微生物组样本,治疗包括鼻用糖皮质激素、口服抗组胺药和/或口服白三烯受体拮抗剂。治疗后鼻部症状总分、含眼部症状的鼻部症状总分及生活质量评分均显著下降(p < 0.001),α多样性无显著变化,组内距离显著减小,葡萄球菌属相对丰度增加而Alloprevotella属减少。

要点

  • 治疗后鼻部症状总分、含眼部症状的鼻部症状总分及生活质量评分均显著下降(p < 0.001)。
  • α多样性无显著变化,但治疗后组内未加权和加权距离均显著减小(p < 0.05)。
  • 治疗后葡萄球菌属相对丰度增加,Alloprevotella属相对丰度减少(p < 0.05)。

核心结论

  • 本研究探讨了慢性鼻炎治疗对鼻腔微生物组的影响及其与症状改善的关联,治疗后鼻腔微生物组的变化可能有助于理解其在慢性鼻炎病理生理和治疗反应中的作用。

研究设计与样本

  • 观察性研究,共纳入22例确诊慢性鼻炎的患者,在治疗前后采集鼻腔微生物组样本,治疗包括鼻用糖皮质激素喷雾、口服抗组胺药和/或口服白三烯受体拮抗剂。

主要发现

  • 治疗后鼻部症状总分、含两个眼部症状的鼻部症状总分及生活质量问卷评分均显著下降(p < 0.001)。
  • α多样性无显著变化,治疗后组内未加权距离和加权距离均显著减小(p < 0.05)。
  • 治疗后葡萄球菌属相对丰度增加,Alloprevotella属相对丰度减少(p < 0.05)。
  • 大多数受试者的优势菌属为葡萄球菌属、不动杆菌属和伯克霍尔德菌科,均与治疗后生活质量改善显著相关(p < 0.05)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Nasal microbiome helps maintain mucosal homeostasis and immune function. Previous studies suggested the pathogenesis of chronic rhinitis and the nasal microbiome were related. This study aimed to evaluate the treatment effect on the nasal microbiome in chronic rhinitis through analyzing microbial diversity and composition in pre- and post-treatment status. METHODS: In participants diagnosed with chronic rhinitis, nasal microbiome samples were collected before and after treatment. Treatment regimens included intranasal corticosteroid spray, oral antihistamines, and/or oral leukotriene receptor antagonists. The degree of symptom improvement was measured by rhinitis symptom questionnaires assessing four nasal symptoms, two ocular symptoms, and quality of life (QOL). Laboratory tests were performed at baseline, including serum total immunoglobulin E, blood eosinophil percentage, and skin prick test. RESULTS: A total of 22 patients were enrolled. Total nasal symptom score (TNSS), TNSS eye (TNSS with two ocular symptoms), and QOL questionnaire scores all significantly decreased after treatment (p < 0.001). Alpha diversity showed no significant changes, while intra-group distances were significantly decreased for both unweighted and weighted distances after treatment (p < 0.05). The relative abundance of Staphylococcus increased, while that of Alloprevotella decreased after treatment (p < 0.05). Predominant genera in most subjects were Staphylococcus, Acinetobacter, and Burkholderiaceae, and all significantly correlated to QOL improvement after treatment (p < 0.05). CONCLUSIONS: This study investigated the impact of chronic rhinitis treatment on the nasal microbiome and its association with symptom improvement. The changes in the nasal microbiome following treatment may enhance our understanding of its role in chronic rhinitis pathophysiology and therapeutic response.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Lee S, Kim G, Seong SM, et al. Nasal Microbial Community Shifts Following Treatment in Chronic Rhinitis: An Observational Study. Laryngoscope. 2025. PMID: 40539731. doi:10.1002/lary.32295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。